Pharmaceutical Portfolio

DS Biopharma Pharmaceutical Portfolio

DS Biopharma (DS) currently has 2 compounds in or starting clinical development and a range of additional compounds in pre-clinical development. DS intends to add more bioactive lipids into the current portfolio in the coming years.